Hetero gets approval to make Roche’s tocilizumab in India under the brand name Tocira

By this month’s end, Hetero is planning on making tocilizumab in India under the brand name Tocira. Hetero is...

Latest news

Orion signs $16 million deal with Jemincare for development of novel non-opioid pain treatment

The deal involves a $16 million payment from Orion to Jemincare with milestones as well as royalty...
- Advertisement -

Several drug recalls hit the US market, including Pfizer’s Accupril

Leading pharmaceutical companies have been hit by recalls recently. These U.S. based drugs  include Jubilant’s Methylprednisolone ,...

Why Focus on Treating Diseases Instead of Curing Them?

It’s a tragic irony: So much money has been poured into treating diseases, but far less into...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC